Measuring biological age using omics data

J Rutledge, H Oh, T Wyss-Coray - Nature Reviews Genetics, 2022 - nature.com
Age is the key risk factor for diseases and disabilities of the elderly. Efforts to tackle age-
related diseases and increase healthspan have suggested targeting the ageing process …

Immortal time bias in pharmacoepidemiology

S Suissa - American journal of epidemiology, 2008 - academic.oup.com
Immortal time is a span of cohort follow-up during which, because of exposure definition, the
outcome under study could not occur. Bias from immortal time was first identified in the …

Postdiagnosis smoking cessation and reduced risk for lung cancer progression and mortality: a prospective cohort study

M Sheikh, A Mukeriya, O Shangina… - Annals of internal …, 2021 - acpjournals.org
Background: Lung cancer is the leading cause of cancer death worldwide, and about one
half of patients with lung cancer are active smokers at diagnosis. Objective: To determine …

Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study

R Ramos, M Comas-Cufí, R Martí-Lluch, E Balló… - bmj, 2018 - bmj.com
Objective To assess whether statin treatment is associated with a reduction in
atherosclerotic cardiovascular disease (CVD) and mortality in old and very old adults with …

Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes

LE Lévesque, JA Hanley, A Kezouh, S Suissa - Bmj, 2010 - bmj.com
Problem of immortal time bias in cohort studies: example using statins for preventing
progression of diabetes | The BMJ Skip to main content Intended for healthcare …

Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis

M Shah, M Avgil Tsadok, CA Jackevicius, V Essebag… - Circulation, 2014 - Am Heart Assoc
Background—Current observational studies on warfarin use and the risk for stroke and
bleeding in patients with atrial fibrillation (AF) undergoing dialysis found conflicting results …

Oral contraceptives, hormone replacement therapy, and stroke risk

T Johansson, P Fowler, WE Ek, A Skalkidou… - Stroke, 2022 - Am Heart Assoc
Background: Millions of women worldwide use exogenous hormones as oral contraceptives
or hormone replacement therapy. Still, time-dependent and long-term consequences of …

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

PM Ho, TM Maddox, L Wang, SD Fihn, RL Jesse… - Jama, 2009 - jamanetwork.com
Context Prior mechanistic studies reported that omeprazole decreases the platelet inhibitory
effects of clopidogrel, yet the clinical significance of these findings is not clear. Objective To …

[PDF][PDF] Vitamin E improves transplant‐free survival and hepatic decompensation among patients with nonalcoholic steatohepatitis and advanced fibrosis

E Vilar‐Gomez, R Vuppalanchi, S Gawrieh… - …, 2020 - Wiley Online Library
Vitamin E improves liver histology in adults with nonalcoholic steatohepatitis (NASH) but not
diabetes, but its impact on long‐term patient outcomes is unknown. We evaluated whether …

Increased mortality after prosthetic joint infection in primary THA

PH Gundtoft, AB Pedersen, C Varnum… - … and Related Research®, 2017 - Springer
Background Revision for prosthetic joint infection (PJI) has a major effect on patients' health
but it remains unclear if early PJI after primary THA is associated with a high mortality …